Syngene International Ltd. News and Updates

Keep track of all breaking news on Syngene International Ltd. from all sources in a single place.

Load latest

Syngene International Ltd.

23 Oct 2024

698.40

2.28%

to see Rapid results content

Syngene International Ltd.

27 Sep 2024

698.40

2.28%

US Biosecure Act To Boost Indian Pharma Sector, Says Syngene International Management

NDTV Profit

India as an economy, and companies like Syngene are possibly the closest in capability and scale to work the Chinese companies off, said Syngene CEO Jonathan Hunt.

Number of FII/FPI investors increased from 337 to 359 in Dec 2024 qtr.

Syngene International Ltd.

10 Sep 2024

698.40

2.28%

Syngene expands supply chain with China-free options

Business Line

Syngene International offers China-independent supply chains, reducing reliance on Chinese suppliers for global biopharma companies

Syngene International Ltd. has lost -21.77% in the last 6 Months

Syngene International Ltd.

26 Aug 2024

698.40

2.28%

Andhra Pradesh pharma company fire accident: Two more injured workers die

Business Standard

The toll rose to three in the flash fire at a pharma company in Anakapalli district as two persons succumbed to burn injuries, an official said on Monday. A chemist and three workers from Jharkhand sustained serious injuries in the accident on August 23 at Syngene Active Ingredients Pvt Ltd, located at Jawaharlal Nehru Pharma City (JN Pharma City) in Parawada. "Two more injured persons died. One person died yesterday night and another person died today (Monday) morning," Anakapalli Superintendent of Police M Deepika Patil told PTI. The lone survivor, Oybon Khora (23) is in a critical condition, she said. Lal Singh Poorthy (22) succumbed to the injuries on Sunday night and the chemist K Suryanarayana (35) died on Monday morning, she said. Prior to the two deaths, Roy Angira (21), also from Jharkhand, died on Saturday. The flash fire occurred around 12:30 am on August 23 when a chemical powder and a chemical liquid were being mixed without following standard operating procedures, ..

Syngene Internationa.. has an average target of 1030.00 from 1 broker.

Syngene International Ltd.

21 Aug 2024

698.40

2.28%

Syngene - Reality Check On Recovery? Stay Positive For Now: Yes Securities

NDTV Profit

Syngene had maintained its outlook for a growth rebound in H2 though subdued commentary by a global peer would likely create a situation where pace of growth delivery might be put under the spotlight.

Number of FII/FPI investors increased from 337 to 359 in Dec 2024 qtr.

Syngene International Ltd.

26 Jul 2024

698.40

2.28%

Syngene International Q1 Results Review - Likelihood Of Growth Surprise Drives An Upgrade: Yes Securities

NDTV Profit

Reckon a changing FY26 growth expectation and worst of biotech woes being behind can result in a higher target multiple, says the brokerage.

Syngene International Ltd. has lost -21.77% in the last 6 Months

Syngene International Ltd.

25 Jul 2024

698.40

2.28%

Syngene International Results Earnings Call for Q1FY25

Conference Call with Syngene International Management and Analysts on Q1FY25 Performance and Outlook. Listen to the full earnings transcript.

audio

Syngene International Ltd.

25 Jul 2024

698.40

2.28%

Syngene Q1 net profit down 19% to 75.7 crore

Business Line

Syngene International's CEO Jonathan Hunt attributes the dip in performance to the reduced funding over the past two years affecting the industry

Number of FII/FPI investors increased from 337 to 359 in Dec 2024 qtr.

Syngene International Q1 Results: Profit Falls 18%, In Line With Estimates

NDTV Profit | 24 Jul 2024

Syngene International Ltd.

24 Jul 2024

698.40

2.28%

to see Rapid results content

Syngene International Ltd.

10 Jun 2024

698.40

2.28%

2 top stock recommendations from Soni Patnaik for near term

Economic Times

The first pick would be in the pharma space, we are seeing quite good momentum here today, so pharma you can see Syngene which is giving you a good fresh breakout above 700 level so I think it is looking quite positive from current levels to test higher targets of 720, 725.